Search PubMed⌕ Search

Biomedical subjects

C Murayama

Publications and source records attributed to C Murayama.

42 records · Page 3Linked to original sources

Radiosensitization of hypoxic HeLa S3 cells in vitro by a new type of radiosensitizer: spermine and spermidine amides with nitro groups.

A new type of hypoxic cell sensitizer (FNT-series compounds) has been developed and tested on HeLa S3 cells. They have two nitrobenzoyl groups at both ends of the spermine or spermidine in their chemical structures. Their ability to sensitize hypoxic cells is greater than that of misonidazole. Among them, N1, N10-bis(4-nitrobenzoyl)-spermidine (FNT-1) was most effective. 1 mM FNT-1 gave a corrected enhancement ratio of 1.71 compared to 1.32 for the same concentration of misonidazole. Its electron affinity, in terms of the half-wave reduction potential, was - 350 mV and higher than that of misonidazole (-395 mV). These FNT-series compounds are thought to interact with DNA in two ways; noncovalent linkage between the basic groups of the polyamine and highly acidic phosphate moieties of the nucleic acid and, secondly, the insertion of the nitrobenzoyl groups between base pairs of the DNA double helix. Since spermine and spermidine themselves did not show any sensitizing activities, it is suggested that the nitrobenzoyl groups which are introduced in spermine and spermidine, play an important role in sensitization.

Cell Survival↗

Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.

Misonidazole, a derivative of 2-nitroimidazole, has selective cytotoxic activity on hypoxic cells in addition to its radiosensitizing activity. This cytotoxicity is considered to be due to metabolic reduction of the drug. A possible metabolite seems to be hydroxylaminomisonidazole, an intermediate product derived via reduction of the nitro group. Authentic samples of hydroxylamino- and aminomisonidazole (a final reduction product) were synthesized and their cytotoxicity towards HeLa S3 cells was compared with that of misonidazole. After a 3-hr exposure to 1mM hydroxylaminomisonidazole under aerobic and hypoxic conditions, the surviving cell fractions were 0.18 and 0.0056, respectively. This represents a cytotoxicity five and 125 times greater, respectively, than that of misonidazole. Under the same conditions, aminomisonidazole showed no apparent cytotoxicity.

Antineoplastic Agents↗

A comparative study on the radiosensitizing effects and cytotoxic properties of misonidazole and 2,4-dinitroimidazole-1-ethanol in HeLa S3 cells.

Hypoxic HeLa S3 cells were used to compare the radiosensitizing and cytotoxic properties of misonidazole and 2,4-dinitroimidazole-1-ethanol. To achieve an enhancement ratio of 1.6 (C1.6), the required concentrations of 2,4-dinitroimidazole-1-ethanol and misonidazole were 0.15 and 2.4mM, respectively; at this ratio, the cytotoxicity values (1/To) of the two compounds were 0.054 hr-1 and 0.29 hr-1. These findings indicate that 2,4-dinitroimidazole-1-ethanol had a greater sensitizing effect at lower cytotoxicity, and that it is therefore the clinically more desirable radiosensitizing compound.

Antineoplastic Agents↗